ABL2: A Non-Receptor Tyrosine Kinase in Cell Signaling and Cancer

Comprehensive genomic and functional overview of ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) from NCBI, Ensembl, UniProt, OMIM, HGNC, COSMIC, and ClinVar.

Gene Information Card

Symbol ABL2
Full Name ABL proto-oncogene 2, non-receptor tyrosine kinase
Gene Type protein-coding
Chromosomal Location 1q25.2
NCBI Gene ID 27 ncbi.nlm.nih.gov/gene/27
Ensembl ID ENSG00000143384
UniProt ID P42684
OMIM ID 164690
HGNC ID 77
Aliases ARG, ABLL, Abelson-related gene

Description

ABL2 (ABL proto-oncogene 2, non-receptor tyrosine kinase) encodes a cytoplasmic tyrosine kinase that regulates cytoskeletal dynamics, cell adhesion, and migration. It shares structural homology with ABL1 and is implicated in cancer progression and neurological disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Chronic Myeloid Leukemia (CML) Fusion with BCR (rare) leading to constitutive kinase activation PMID: 10666374
Solid tumors (e.g., breast, lung) Overexpression and aberrant activation promoting invasion PMID: 21804562
Intellectual disability De novo missense variants affecting kinase activity ClinVar: VCV000429586

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Lung 8.3 Low
Breast 6.7 Low
Testis 15.2 Medium
Cell Line Expression
Cell Line nTPM Notes
K562 (CML) 18.4 High expression; BCR-ABL1 negative control
MCF7 (breast) 9.1 Moderate
HEK293 7.5 Low
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Gly2Arg Missense <0.1% Impaired kinase activity (ClinVar)
p.Arg171Trp Missense <0.1% Loss of function (ClinVar)
p.Glu255Lys Missense <0.1% Gain of function (COSMIC)
Mutation functional classification

Loss of Function (LOF)

Missense variants in the kinase domain (e.g., p.Gly2Arg) reduce catalytic activity.

Gain of Function (GOF)

Rare mutations (e.g., p.Glu255Lys) enhance kinase activity and promote oncogenic signaling.

Dominant Negative (DN)

Not well characterized; some truncating mutations may interfere with wild-type function.

Pathways

• Rho GTPase cycle (Reactome: R-HSA-194840)
• Signaling by Receptor Tyrosine Kinases (Reactome: R-HSA-9006934)
• FCERI mediated MAPK activation (Reactome: R-HSA-2871796)

Protein Summary

ABL2 (ARG) is a 1182-amino acid non-receptor tyrosine kinase with SH2, SH3, and actin-binding domains. It localizes to the cytoplasm and cytoskeleton, regulating cell motility and adhesion. Its kinase activity is tightly regulated; aberrant activation contributes to tumor invasion and metastasis.

Related Products

Product name Cat.No. Species Gene ID
ABL2 Knockout HeLa Cell Line EDJ-KQ20678 Human 27 Details Get a Quote
ABL2 Knockout A-549 Cell Line EDJ-KQ20677 Human 27 Details Get a Quote
ABL2 Knockout HCT 116 Cell Line EDJ-KQ19330 Human 27 Details Get a Quote
ABL2 Knockout HEK293 Cell Line EDJ-KQ17799 Human 27 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: